[1] Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int, 2010, 4:439-474
[2] Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology, 2005, 42:1208-1236.
[3] Hirooka M, Ishida K, Kisaka Y, et al. Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma. Hepatol Res, 2008, 38: 1172.
[4] Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology, 2011, 53: 1020-1022.
[5] Amin MA, el-Gendy MM, Dawoud IE, et al. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg, 2009, 33: 1702-1710
[6] Li WX, Zhao XT, Chai WM, et al. Hepatitis B virus-induced liver fibrosis and cirrhosis: the value of liver and spleen volumetry with multi-detector spiral computed tomography. J Dig Dis, 2010,11:215-223.
[7] 刘允怡, 赖俊雄, 刘晓欣. 手术切除在肝癌多学科综合治疗中的地位. 中国实用外科杂志, 2014, 34: 677-680.
[8] Nathan H, Schulick RD, Choti MA, et al. Predictors of survival after resection of early hepatocellular carcinoma. Annals of Surgery, 2009, 249: 799.
[9] Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg, 2005, 201:656-662.
[10] Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 1999, 19: 329-338.
[11] Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England J Med, 1996, 334: 693.
[12] Choi SB, Kim HJ, Song TJ, et al. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.J Hepatobiliary Pancreat Sci, 2014, 21: 639-647.
[13] Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatology Research, 2008, 38: 1159-1171.
[14] Kawanaka H, Akahoshi T, Kinjo N, et al. Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Sur, 2009, 16: 749.
[15] Chen XP, Wu ZD, Huang ZY, et al. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. British J Surg, 2005, 92: 334.
[16] Takeishi K, Kawanaka H, Itoh S, et al. Impact of splenic volume and splenectomy on prognosis of hepatocellular carcinoma within milan criteria after curative hepatectomy. World J Surg, 2017: 1-9.
[17] Kinjo N, Nagao Y, Akahoshi T, et al. Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients. Hepatol Res, 2013, 43: 933-941.
[18] Takeishi K, Maeda T, Tsujita E, et al. Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma. Anticancer Res, 2015, 35: 3061-3066.
[19] Shiha G, Sarin SK, Ibrahim AE, et al. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int, 2009, 3:323-333.
[20] Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol, 2010, 8: 877-883.
[21] Liu P, Li P, He W, et al. Liver and spleen volume variations in patients with hepatic fibrosis. World J Gastroenterol, 2009, 15: 3298-3302
[22] Bolognesi M, Merkel C, Sacerdoti D, et al. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis, 2002, 34:144-150.
[23] Huang Y, Huang B, Kan T, et al. Liver-to-spleen ratio as an index of chronic liver diseases and safety of hepatectomy: a pilot study. World J Surg, 2014, 38: 3186-3192.
[24] Wu WC, Chiou YY, Hung HH, et al. Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation. JClin Gastroenterol, 2012, 46: 789-795.
[25] Poon RT, Fan S, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 2000, 89: 500-507.
[26] Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg, 2006, 243: 229.
[27] Murata K, Ito K, Yoneda K, et al. Splenectomy improves liver function in patients with liver cirrhosis. Hepato-gastroenterology, 2008, 55: 1407-1411.
[28] Hashimoto N, Shimoda S, Kawanaka H, et al. Modulation of CD4 T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clinical & Exp Immunol, 2011, 165: 243.
[29] Prassopoulos P, Daskalogiannaki M, Raissaki M, et al. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol, 1997,7: 246-248. |
